Your browser doesn't support javascript.
loading
Efficacy of a non-pharmaceutical multimodal intervention program in a group setting for patients with mild cognitive impairment: A single-arm interventional study with pre-post and external control analyses.
Nakagawa, Satoshi; Kowa, Hisatomo; Takagi, Yumi; Kakei, Yasumasa; Kagimura, Tatsuo; Sanada, Shoji; Nagai, Yoji.
Afiliación
  • Nakagawa S; Division of Translational Science, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
  • Kowa H; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Takagi Y; Division of Cognitive and Psychiatric Rehabilitation, Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Hyogo, Japan.
  • Kakei Y; Department of Clinical Biostatistics, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan.
  • Kagimura T; Clinical and Translational Research Centre, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Sanada S; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Nagai Y; Division of Translational Science, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Contemp Clin Trials Commun ; 40: 101326, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39021673
ABSTRACT

Aim:

This study aimed to evaluate the efficacy of a non-pharmaceutical multimodal intervention program consisting of physical exercise, cognitive stimulation, and health education in a group setting to slow the progression of mild cognitive impairment (MCI).

Methods:

A single-arm interventional study was conducted on 27 patients with MCI. To evaluate the efficacy of the intervention program, a pre-post analysis was performed using EuroQol-5 Dimension (EQ-5D), Mini-Mental State Examination (MMSE), Cognitive Function Instrument (CFI), 5 Cog test, depression, and physical performance before and after the 8-month intervention. Additionally, propensity score and the semi-Bayes analyses were performed to compare the intervention program with standard medical care, using the external control patients' data for MMSE scores.

Results:

Twenty-four patients completed the intervention program. During the study period, although EQ-5D and MMSE scores remained unchanged (mean change 0.02 [95 % confidence interval (CI) -0.004, 0.04], 0.5 [-0.2, 1.3]), CFI and the subcategories of 5Cog (attention and reasoning) improved (mean change -1.23 [-2.24, -0.21], 4.3 [0.9, 7.7], 3.0 [0.4, 5.6]). In the additional analysis comparing changes in MMSE scores, patients who underwent the intervention program had less decline than the external control patients (mean change -1.7 [-2.1, -1.3]) with an observed mean difference of 2.25 [1.46, 3.03], and propensity score-adjusted difference of 2.26 [1.46, 3.05]. The semi-Bayesian approach also suggested that the intervention slowed the progression of MCI.

Conclusion:

A non-pharmaceutical multimodal intervention program could contribute to slowing cognitive decline in patients with MCI.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Contemp Clin Trials Commun Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Contemp Clin Trials Commun Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos